Why the study?
Ablation outside the pulmonary veins is sometimes needed in persistent or longstanding AF, prompting evaluation of cryoballoon left atrial appendage isolation.
Does CMAP plus ICE-B guided LAAI using cryoballoon safely achieve durable isolation and prevent recurrence in patients with recurrent persistent AF?
Does CMAP plus ICE-B guided LAAI using cryoballoon safely achieve durable isolation and prevent recurrence in patients with recurrent persistent AF?
CMAP-guided cryoballoon LAA isolation using the ICE-B protocol is feasible, safe, and achieves high rates of durable isolation and short-term rhythm control in patients with recurrent persistent AF.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for cryoballoon LAA isolation in persistent AF; leaves open need for RCTs to confirm safety and efficacy.
Introduction Pulmonary vein isolation (PVI) is the cornerstone ablation strategy for treatment of atrial fibrillation (AF). Ablation outside the PVs is sometimes needed particularly in persistent or longstanding AF. This study reported left atrial appendage isolation (LAAI) using cryoballoon (CB) focusing on technical data and short‐term clinical follow‐up. Methods and results Patients with recurrent persistent AF after multiple AF procedures were enrolled. LAAI was performed using the second generation CB guided by compound motor action potential (CMAP) and 240 seconds plus bonus freeze (ICE‐B) protocol. Ten patients were included, median age was 69.5 (56‐73) years, CHA 2 DS 2 ‐VASc score was 3 (1.8‐4), LA diameter was 44 (38.8‐46.5) mm. All patients had a mean of three AF procedures before the LAAI procedure. All patients were under successful CMAP guidance. During the CB LAAI procedure, the median time to LAA isolation was 100 (76‐270) seconds, minimal freeze temperature was −50 (−57 to −47)°C. A “pull‐down (or pull‐away)” CB maneuver was performed in all patients. Median fluoroscopic time was 4.8 (3.4‐6.8) minutes and acute LAAI success rate was 100%. No phrenic nerve injury or other major complications were observed. At 6‐week follow‐up, remapping of the LAA showed durable isolation of all PVs (100%), all patients were scheduled for LAA occlusion. Six‐month follow‐up showed that 80% of patients were free from AF/AT recurrence. Conclusion CMAP plus ICE‐B guided LAAI using cryo‐technology appears feasible and safe, results in durable LAAI, and shows promising clinical results in patients with recurrent persistent AF.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: